$Moderna, Inc.(MRNA)$ Moderna,

Moderna, partnering with Merck, expects to launch a personalized cancer vaccine by 2027. A late-stage skin cancer vaccine trial is fully enrolled, showing promise over Keytruda, with plans to expand to other cancers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":410538701672512,"tweetId":"410538701672512","gmtCreate":1741238718346,"gmtModify":1741238723144,"author":{"id":10000000000011028,"idStr":"10000000000011028","authorId":10000000000011028,"authorIdStr":"10000000000011028","name":"DeltaDrift","avatar":"https://community-static.tradeup.com/news/11d675a610354289230d3a2f6c6e4c88","vip":8,"userType":8,"introduction":"Drifting on Volatility","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":119,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/718ac093ece0ae85c2182ed8218871eb","width":"937","height":"642"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/718ac093ece0ae85c2182ed8218871eb","width":"937","height":"642"}],"html":"<html><head></head><body> <a data-mention-id=\"MRNA\" class=\"teditor-mention\" data-mention-name=\"Moderna, Inc.\" href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$</a><v-v data-views=\"1\"></v-v>Moderna, partnering with Merck, expects to launch a personalized cancer vaccine by 2027. A late-stage skin cancer vaccine trial is fully enrolled, showing promise over Keytruda, with plans to expand to other cancers.<img src=\"https://community-static.tradeup.com/news/718ac093ece0ae85c2182ed8218871eb\" tg-width=\"937\" tg-height=\"642\"></body></html>","htmlText":"<html><head></head><body> <a data-mention-id=\"MRNA\" class=\"teditor-mention\" data-mention-name=\"Moderna, Inc.\" href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$</a><v-v data-views=\"1\"></v-v>Moderna, partnering with Merck, expects to launch a personalized cancer vaccine by 2027. A late-stage skin cancer vaccine trial is fully enrolled, showing promise over Keytruda, with plans to expand to other cancers.<img src=\"https://community-static.tradeup.com/news/718ac093ece0ae85c2182ed8218871eb\" tg-width=\"937\" tg-height=\"642\"></body></html>","text":"$Moderna, Inc.(MRNA)$ Moderna, partnering with Merck, expects to launch a personalized cancer vaccine by 2027. A late-stage skin cancer vaccine trial is fully enrolled, showing promise over Keytruda, with plans to expand to other cancers.","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/410538701672512","repostId":0,"isVote":1,"tweetType":1,"viewCount":796,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["MRNA"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":true,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":204,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/410538701672512"}